July 17th, 2023
Advanced radiotherapy treatments for Oropharyngeal cancer have improved patient survival rates, although they lead to understudied long-term symptoms. By analyzing three-dimensional dose distributions to vital organs via custom unsupervised machine learning, we identify correlations with long-term patient-reported symptoms. Our innovative approach surpasses existing clinical guidelines, offering actionable insights for optimizing treatment plans and minimizing post-treatment side effects.
This work by visual computing researchers at EVL is in collaboration with clinicians at MD Anderson Cancer Center from Texas and data mining specialists at University of Iowa, and it is supported by funding from the US National Institutes of Health (NIH awards NCI-R01-CA258827 and NLM-R01-LM012527), and US National Science Foundation (NSF awards CDSE-1854815 and CNS-1828265).